CompanyHealthcare Therapeutics
Kernal Biologics
Kernal Biologics develops innovative mRNA 2.0 therapies that specifically target cancer cells, enabling them to produce their own medicine while sparing healthy cells, demonstrating high efficacy and safety.
BiotechGenomics